162 related articles for article (PubMed ID: 33371107)
41. Use of comparative effectiveness research for similar Chinese patent medicine for angina pectoris of coronary heart disease: a new approach based on patient-important outcomes.
Cao H; Zhai J; Mu W; Lei X; Cao H; Liu C; Shang H
Trials; 2014 Mar; 15():84. PubMed ID: 24641790
[TBL] [Abstract][Full Text] [Related]
42. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
[TBL] [Abstract][Full Text] [Related]
43. The efficacy and safety of FcRn inhibitors in patients with myasthenia gravis: a systematic review and meta-analysis.
Li J; Wu X; Chu T; Tan X; Wang S; Qu R; Chen Z; Wang Z
J Neurol; 2024 May; 271(5):2298-2308. PubMed ID: 38431900
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial.
Piehl F; Eriksson-Dufva A; Budzianowska A; Feresiadou A; Hansson W; Hietala MA; Håkansson I; Johansson R; Jons D; Kmezic I; Lindberg C; Lindh J; Lundin F; Nygren I; Punga AR; Press R; Samuelsson K; Sundström P; Wickberg O; Brauner S; Frisell T
JAMA Neurol; 2022 Nov; 79(11):1105-1112. PubMed ID: 36121672
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy.
Long W; Liao H; Huang X; Liu Q; Tang Y; Lu L; Liu J; Yuan T; Ling Y; Hong Y; Duan J; Lin W; Xian S; Yang Z
BMJ Open; 2020 Aug; 10(8):e038074. PubMed ID: 32847917
[TBL] [Abstract][Full Text] [Related]
46. Investigation of Invigorating
Wang Y; Zhang L; Pan YJ; Fu W; Huang SW; Xu B; Dou LP; Hou Q; Li C; Yu L; Zhou HF; Yang JH; Wan HT
Front Pharmacol; 2020; 11():892. PubMed ID: 32625091
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of Chinese herbal medicine Jiangniaosuan formula for treatment of hyperuricemia: study protocol for a double-blinded non-inferiority randomized controlled clinical trial.
Guo Y; Lu H; Gan J; Li D; Gao J; Zhang C
Trials; 2022 Jan; 23(1):1. PubMed ID: 34980237
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial.
Deng C; Lou Y; Gao Y; Deng B; Su F; Jia L
Trials; 2020 May; 21(1):370. PubMed ID: 32357899
[TBL] [Abstract][Full Text] [Related]
49. Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
Bril V; Szczudlik A; Vaitkus A; Rozsa C; Kostera-Pruszczyk A; Hon P; Bednarik J; Tyblova M; Köhler W; Toomsoo T; Nowak RJ; Mozaffar T; Freimer ML; Nicolle MW; Magnus T; Pulley MT; Rivner M; Dimachkie MM; Distad BJ; Pascuzzi RM; Babiar D; Lin J; Querolt Coll M; Griffin R; Mondou E
Neurology; 2023 Feb; 100(7):e671-e682. PubMed ID: 36270895
[TBL] [Abstract][Full Text] [Related]
50. Chinese herbal medicine for the treatment of cough variant asthma: a study protocol for a double-blind randomized controlled trial.
Fan RR; Wen ZH; Wang DW; Yang RY; Ou AH; Jin LS; Zhang ZD; Liu YT
Trials; 2019 Jan; 20(1):3. PubMed ID: 30606237
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of Qi-Wei-Qing-Yan aerosol in treatment of acute pharyngitis (lung-stomach excess-heat syndrome): study protocol for a randomized controlled trial.
Jiang HL; She B; Liu W; Mao B; Zhang JY
Trials; 2016 Feb; 17():99. PubMed ID: 26896352
[TBL] [Abstract][Full Text] [Related]
52. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
McPherson T; Aban I; Duda PW; Farzaneh-Far R; Wolfe GI; Kaminski HJ; Cutter G; Lee I;
Muscle Nerve; 2020 Aug; 62(2):261-266. PubMed ID: 32369631
[TBL] [Abstract][Full Text] [Related]
53. [Yunchang Capsule in treatment of functional constipation: a randomized, double-blinded controlled, multicenter trial].
Guo J; Zhang RM; Huang ZW; Wang L; Liu SS; Diao JC; Hu SY; Lin BH
Zhong Xi Yi Jie He Xue Bao; 2009 Dec; 7(12):1123-9. PubMed ID: 20015431
[TBL] [Abstract][Full Text] [Related]
54. Oral traditional Chinese medication for adhesive small bowel obstruction.
Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
[TBL] [Abstract][Full Text] [Related]
55. Traditional Chinese medicine for myasthenia gravis: Study protocol for a network meta-analysis.
Xie R; Liu L; Wang R; Huang C
Medicine (Baltimore); 2020 Jul; 99(29):e21294. PubMed ID: 32702924
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of Zihua Wenfei granules in treatment of postinfectious cough (wind-cold invading lungs syndrome): study protocol for a randomized controlled trial.
Wang H; She B; Mao B; Jiang H
Trials; 2020 Jun; 21(1):547. PubMed ID: 32560739
[TBL] [Abstract][Full Text] [Related]
57. Lymphoplasma Exchange Improves Myasthenia Gravis Exacerbations: A Retrospective Study in a Chinese Center.
Ouyang S; Yin W; Zeng Q; Li B; Zhang J; Duan W; Li Y; Liang Y; Wang J; Tan H; Yang H
Front Immunol; 2022; 13():757841. PubMed ID: 35514988
[TBL] [Abstract][Full Text] [Related]
58. Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial.
Wu R; Wei F; Qu L; Bai L; Li J; Li F; Yan W; Wang Q; Wei J
Trials; 2020 Nov; 21(1):951. PubMed ID: 33228726
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of Shu-gan-qing-re formula for generalized anxiety disorder: study protocol for a multi-center, prospective, double-blind, double-dummy, randomized controlled trial.
Chen P; Zhu H; Ning Y; Yin D; Jia H
Trials; 2020 Mar; 21(1):266. PubMed ID: 32171323
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial.
Bril V; Benatar M; Andersen H; Vissing J; Brock M; Greve B; Kiessling P; Woltering F; Griffin L; Van den Bergh P;
Neurology; 2021 Feb; 96(6):e853-e865. PubMed ID: 33219142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
